StockWatch
·
Pharmaceuticals
Buyback18 Jun 2026, 12:00 pm

Zydus Lifesciences Completes ₹1100 Cr Share Buyback

AI Summary

Zydus Lifesciences Limited has announced the completion of its share buyback program. The company repurchased 87,30,158 equity shares, representing 0.87% of its paid-up capital, at a price of ₹1,260 per share. The total buyback size amounted to ₹1,100 crore. This action was conducted on a proportionate basis through a tender offer route, in compliance with SEBI regulations. The company has published a post-buyback advertisement in English, Hindi, and Gujarati newspapers to inform shareholders.

Key Highlights

  • Company completed share buyback of ₹1,100 crore.
  • 87,30,158 shares repurchased at ₹1,260 each.
  • Buyback represented 0.87% of total equity share capital.
  • Transaction executed via tender offer route.
  • Compliance with SEBI Buyback Regulations confirmed.